Meros Equity
Personal Account
Legend Biotech
IPO LEGN.NASDAQ Past

Legend Biotech

Biopharmaceutical company bringing impactful innovations in cell therapy

Company website
Ticker

LEGN.NASDAQ

Market

us

Foundation year

2014

Potential

157%

Close date

6/9/2020

IPO date

6/4/2020

Placement price

$23

Open price

$37

Profitability

57.87%

About

Total Funding 

$150.5M

Legend Biotech is a biopharmaceutical company bringing impactful innovations in cell therapy, and accelerating the science. They are committed to improving the lives of patients worldwide. They are also steadfast in their goal to develop innovative cellular therapies that bring us closer to a cure. It develops cell therapies from discovery through

commercialization.

Meros Equity

2022 © All rights reserved

You can always come to our office to discuss any questions with our manager

Dubai

Sharjah Media City, Sharjah, UAE

USA

500 Delaware ave,
STE 1 #1960 Wilmington, DE, USA

Czech Republic

Czech Republic, Prague, Bilkova 855/19

The investment opportunities posted on this website's Pre-IPO section are private placements of securities that are not traded on the open market, subject to the ownership period requirements, and intended for investors who do not require liquid investments. Investments in private companies may be considered speculative, involving high risk, including the significant loss of investment risk. Investors must be able to afford to lose all their investments.